The assessment of regional and global myocardial function, myocardial tissue characterization, and ischemia by cardiac magnetic resonance (CMR) imaging has become an integrated part of the diagnostic armamentarium in cardiology.1 Combined scan protocols providing detailed diagnostic information on ventricular wall motion, myocardial viability, and vasodilator stress perfusion are performed during routine evaluation of patients with coronary artery disease (CAD) and deliver valuable information for accurate prognostication (Figure 1; Movie 1 in Supplementary material).2 In general, ischemia detection represents the mainstay of risk stratification and therapeutic decision making in patients with CAD. Hence, the diagnostic module “ischemia detection” is rightfully considered a key component of a comprehensive CMR examination (Figure 2; Movie 2 in Supplementary material). With CMR imaging, pharmacological stress is usually preferred and dobutamine or adenosine is used to provoke regional wall motion or perfusion abnormalities being indicative of an ischemic reaction of the myocardium. In addition, CMR imaging represents an excellent tool for the assessment of myocardial viability, since it offers the unique possibility to visualize myocardial scar tissue with high contrast and with sub-millimeter spatial resolution. The so-called late gadolinium enhancement (LGE) technique has been extensively researched and is now widely accepted as a reference standard to detect the presence and to directly quantify the extent and severity of myocardial scar in chronically injured myocardium. Regarding the CMR protocol aiming at ischemia detection, a high diagnostic performance was reported in several studies by analysis of the vasodilator stress data in combination with subsequent LGE imaging which favors a stress-only protocol.3 The diagnostic values of CMR perfusion techniques were reported in a large meta-analysis and yielded a sensitivity and specificity of 0.91 (95% CI 0.88 to 0.94) and 0.81 (95% CI 0.77 to 0.85) on a per patient level, respectively.4
Three-dimensional contrast-enhanced and non-contrast-enhanced cardiac magnetic resonance imaging for the assessment of myocardial ischemic reactions The practice of looking deeply into the myocardium
Authors
Cosima Jahnke, MD Sebastian Kozerke, PhD Bernhard Schnackenburg, PhD Nikolaus Marx, MD Ingo Paetsch, MD